Odysight.ai Reports 96% Revenue Decline, Increased Losses, and Higher Cash Burn in Q1 2026
ODYS sits 74% above its 52-week low of $2.6.
Summary
Odysight.ai Inc. reported a drastic 96% drop in Q1 2026 revenue, coupled with increased operating losses and a significant rise in cash burn, raising immediate liquidity concerns despite management's 12-month runway projection.
Key Events · Earnings and Guidance · ODYS
-
Revenue Plummets 96%
Revenues for Q1 2026 decreased by 96% to $82,000, down from $2,065,000 in Q1 2025, primarily due to the derecognition of a medical contract and geopolitical delays.
-
Operating Loss Increases 17%
Operating loss widened to $5,338,000 in Q1 2026, an increase of 17% from $4,560,000 in Q1 2025.
-
Cash Burn Nearly Doubles
Cash used in operating activities increased significantly to $4,254,000 in Q1 2026, compared to $2,233,000 in Q1 2025, reducing cash and cash equivalents to $21.8 million.
-
New Chief Operating Officer Appointed
Ronen Tanami was appointed Chief Operating Officer, effective May 13, 2026, and will be granted options to purchase 100,000 shares of common stock.
Analysis · ODYS · Technology
Odysight.ai Inc. reported a severe financial deterioration in Q1 2026, with revenues plummeting by 96% year-over-year, primarily due to the derecognition of a medical contract and geopolitical delays. This led to a significant increase in operating and net losses, alongside a near doubling of cash used in operating activities. While management states current cash resources will fund operations for at least the next 12 months, the accelerated cash burn raises concerns about future liquidity. The company also announced the appointment of a new Chief Operating Officer and noted the recent dual listing on the Tel Aviv Stock Exchange, but these positive developments are overshadowed by the poor financial performance.
At the time of this filing, ODYS was trading at $4.52 on NASDAQ in the Technology sector, with a market capitalization of approximately $73.9M. The 52-week trading range was $2.60 to $11.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.